Clayton, Benjamin L. L. http://orcid.org/0000-0001-9552-404X
Kristell, James D.
Allan, Kevin C.
Cohn, Erin F.
Karl, Molly
Jerome, Andrew D.
Garrison, Eric
Maeno-Hikichi, Yuka
Sturno, Annalise M.
Kerr, Alexis
Shick, H. Elizabeth
Sepeda, Jesse A. http://orcid.org/0009-0005-0227-0156
Freundt, Eric C.
Sas, Andrew R.
Segal, Benjamin M.
Miller, Robert H.
Tesar, Paul J. http://orcid.org/0000-0003-1532-3155
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R35NS116842, F31NS124282, T32NS077888)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA043703)
U.S. Department of Health & Human Services | NIH | NIH Officeof the Director (S10OD016164)
National Multiple Sclerosis Society (TA-2105-37619)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (F30HD096784)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007250, T32GM007250)
U.S. Department of Health & Human Services | NIH | National Eye Institute (K08EY029362)
Article History
Received: 31 May 2023
Accepted: 15 January 2024
First Online: 20 February 2024
Competing interests
: B.L.L.C. and P.J.T. are listed as inventors on pending patent claims filed by Case Western Reserve University covering methods and compositions for treating neurodegenerative disorders. The other authors declare no competing interests.